Publications 2005-2004
Akhwale, W. S., Lum, J. K., Kaneko, A., Eto, H., Obonyo, C., Bjorkman, A. and Kobayakawa, T. (2004). Anemia and malaria at different altitudes in the western highlands of Kenya. Acta Trop 91, 167-75.
Bhattarai, A., Maini-Thapar, M., Ali, A. S. and Bjorkman, A. (2004). Amodiaquine during pregnancy. Lancet Infect Dis 4, 721-2; discussion 722.
Bjorkman, A. (2004). [Intervention against malaria requires international solidarity. Institutions and drug industry should find new forms of collaboration]. Lakartidningen 101, 384-8.
Bjorkman, A. and Bhattarai, A. (2005). Public health impact of drug resistant Plasmodium falciparum malaria. Acta Trop 94, 163-9.
Cavaco, I., Stromberg-Norklit, J., Kaneko, A., Msellem, M. I., Dahoma, M., Ribeiro, V. L., Bjorkman, A. and Gil, J. P. (2005a). CYP2C8 polymorphism frequencies among malaria patients in Zanzibar. Eur J Clin Pharmacol 61, 15-8. Epub 2005 Jan 27.
Cavaco, I., Stromberg-Norklit, J., Kaneko, A., Msellem, M. I., Dahoma, M., Ribeiro, V. L., Bjorkman, A. and Gil, J. P. (2005b). CYP2C8 polymorphism frequencies among malaria patients in Zanzibar. Eur J Clin Pharmacol 27, 27.
Farnert, A. and Bjorkman, A. (2005). Limited advantage of multiple consecutive samples for genotyping Plasmodium falciparum populations during the first days of treatment. Am J Trop Med Hyg 73, 204-6.
Gil, J. P., Sisowath, C. and Bjorkman, A. (2005). Reply to hastings and ward. J Infect Dis 192, 1304-5.
Holmgren, G., Gil, J. P., Ferreira, P. M., Veiga, M. I., Obonyo, C. O. and Bjorkman, A. (2005). Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol 31, 31.
Hugosson, E., Montgomery, S. M., Premji, Z., Troye-Blomberg, M. and Bjorkman, A. (2004). Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol 26, 111-7.
Lum, J. K., Kaneko, A., Tanabe, K., Takahashi, N., Bjorkman, A. and Kobayakawa, T. (2004). Malaria dispersal among islands: human mediated Plasmodium falciparum gene flow in Vanuatu, Melanesia. Acta Trop 90, 181-5.
Mariga, S. T., Gil, J. P., Sisowath, C., Wernsdorfer, W. H. and Bjorkman, A. (2004). Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 48, 4089-96.
Mariga, S. T., Gil, J. P., Wernsdorfer, W. H. and Bjorkman, A. (2005). Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro. Acta Trop 93, 221-31.
Martensson, A., Stromberg, J., Sisowath, C., Msellem, M. I., Gil, J. P., Montgomery, S. M., Olliaro, P., Ali, A. S. and Bjorkman, A. (2005). Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis 41, 1079-86. Epub 2005 Sep 13.
Mita, T., Kaneko, A., Lum, J. K., Bwijo, B., Takechi, M., Zungu, I. L., Tsukahara, T., Tanabe, K., Kobayakawa, T. and Bjorkman, A. (2003). Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 68, 413-5.
Mita, T., Kaneko, A., Lum, J. K., Zungu, I. L., Tsukahara, T., Eto, H., Kobayakawa, T., Bjorkman, A. and Tanabe, K. (2004). Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol 135, 159-63.
Muhlberger, N., Jelinek, T., Gascon, J., Probst, M., Zoller, T., Schunk, M., Beran, J., Gjorup, I., Behrens, R. H., Clerinx, J. et al. (2004). Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 3, 5.
Sisowath, C., Stromberg, J., Martensson, A., Msellem, M., Obondo, C., Bjorkman, A. and Gil, J. P. (2005). In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 191, 1014-7. Epub 2005 Feb 8.
Thapar, M. M., Gil, J. P. and Bjorkman, A. (2005). In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil. Trans R Soc Trop Med Hyg 99, 62-70.
Thapar, M. M., Gupta, S., Spindler, C., Wernsdorfer, W. H. and Bjorkman, A. (2003). Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 97, 331-7.
Zakeri, S., Bereczky, S., Naimi, P., Pedro Gil, J., Djadid, N. D., Farnert, A., Snounou, G. and Bjorkman, A. (2005). Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran. Trop Med Int Health 10, 1060-4.
Bhattarai, A., Maini-Thapar, M., Ali, A. S. and Bjorkman, A. (2004). Amodiaquine during pregnancy. Lancet Infect Dis 4, 721-2; discussion 722.
Bjorkman, A. (2004). [Intervention against malaria requires international solidarity. Institutions and drug industry should find new forms of collaboration]. Lakartidningen 101, 384-8.
Bjorkman, A. and Bhattarai, A. (2005). Public health impact of drug resistant Plasmodium falciparum malaria. Acta Trop 94, 163-9.
Cavaco, I., Stromberg-Norklit, J., Kaneko, A., Msellem, M. I., Dahoma, M., Ribeiro, V. L., Bjorkman, A. and Gil, J. P. (2005a). CYP2C8 polymorphism frequencies among malaria patients in Zanzibar. Eur J Clin Pharmacol 61, 15-8. Epub 2005 Jan 27.
Cavaco, I., Stromberg-Norklit, J., Kaneko, A., Msellem, M. I., Dahoma, M., Ribeiro, V. L., Bjorkman, A. and Gil, J. P. (2005b). CYP2C8 polymorphism frequencies among malaria patients in Zanzibar. Eur J Clin Pharmacol 27, 27.
Farnert, A. and Bjorkman, A. (2005). Limited advantage of multiple consecutive samples for genotyping Plasmodium falciparum populations during the first days of treatment. Am J Trop Med Hyg 73, 204-6.
Gil, J. P., Sisowath, C. and Bjorkman, A. (2005). Reply to hastings and ward. J Infect Dis 192, 1304-5.
Holmgren, G., Gil, J. P., Ferreira, P. M., Veiga, M. I., Obonyo, C. O. and Bjorkman, A. (2005). Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol 31, 31.
Hugosson, E., Montgomery, S. M., Premji, Z., Troye-Blomberg, M. and Bjorkman, A. (2004). Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol 26, 111-7.
Lum, J. K., Kaneko, A., Tanabe, K., Takahashi, N., Bjorkman, A. and Kobayakawa, T. (2004). Malaria dispersal among islands: human mediated Plasmodium falciparum gene flow in Vanuatu, Melanesia. Acta Trop 90, 181-5.
Mariga, S. T., Gil, J. P., Sisowath, C., Wernsdorfer, W. H. and Bjorkman, A. (2004). Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 48, 4089-96.
Mariga, S. T., Gil, J. P., Wernsdorfer, W. H. and Bjorkman, A. (2005). Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro. Acta Trop 93, 221-31.
Martensson, A., Stromberg, J., Sisowath, C., Msellem, M. I., Gil, J. P., Montgomery, S. M., Olliaro, P., Ali, A. S. and Bjorkman, A. (2005). Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis 41, 1079-86. Epub 2005 Sep 13.
Mita, T., Kaneko, A., Lum, J. K., Bwijo, B., Takechi, M., Zungu, I. L., Tsukahara, T., Tanabe, K., Kobayakawa, T. and Bjorkman, A. (2003). Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 68, 413-5.
Mita, T., Kaneko, A., Lum, J. K., Zungu, I. L., Tsukahara, T., Eto, H., Kobayakawa, T., Bjorkman, A. and Tanabe, K. (2004). Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol 135, 159-63.
Muhlberger, N., Jelinek, T., Gascon, J., Probst, M., Zoller, T., Schunk, M., Beran, J., Gjorup, I., Behrens, R. H., Clerinx, J. et al. (2004). Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 3, 5.
Sisowath, C., Stromberg, J., Martensson, A., Msellem, M., Obondo, C., Bjorkman, A. and Gil, J. P. (2005). In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis 191, 1014-7. Epub 2005 Feb 8.
Thapar, M. M., Gil, J. P. and Bjorkman, A. (2005). In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil. Trans R Soc Trop Med Hyg 99, 62-70.
Thapar, M. M., Gupta, S., Spindler, C., Wernsdorfer, W. H. and Bjorkman, A. (2003). Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 97, 331-7.
Zakeri, S., Bereczky, S., Naimi, P., Pedro Gil, J., Djadid, N. D., Farnert, A., Snounou, G. and Bjorkman, A. (2005). Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran. Trop Med Int Health 10, 1060-4.
posted by Chikilin @ 6:36 AM
0 comments
